PD Dr. med. Tsogyal Latshang

• FMH Pneumologie (2009)
• FMH Innere Medizin (2006)
  
• European Diploma in Adult Respiratory Medicine (2009)
  
• Basiskurs Didaktik für Habilitandinnen und Habilitanden, Medizinische Fakultät der Universität Zürich (2010)
• Fähigkeitsausweis für Schlafmedizin der SGSSC (2010)
• Certified Expert Somnologist 2017 European Sleep Research Society (ESRS)
  
• "Diving Medicine Physician", Schweizerische Gesellschaft für Unterwasser- und Hyperbarmedizin (2013)
  
• BAG anerkannter Sachverständiger Durchleuchten Typ B dosisintensive Untersuchungen und therapeutische Eingriffe in der Pneumologie
  
• Good Clinical Practice Module 1-3 (2009)
• Schweizerisches eidgenössisches Ärztediplom, Universität Bern (2000)
  
  
  
  

• Arbeitsgruppe Schlafapnoe, Schweizerische Gesellschaft für Pneumologie
  
• Vorstandsmitglied Schweizerische Gesellschaft für Schlafforschung, Schlafmedizin und Chronobiologie
  
• European Respiratory Society, American Thoracic society
  
• Schweizerische Gesellschaft für Innere Medizin und für Pneumologie
  
• Schweizerische Gesellschaft für Unterwasser- und Hyperbarmedizin
  

1. Swiss Society of Sleep Research, Sleep Medicine and Chronobiology (SSSSC) Sponsor`s Award for the best clinical paper 2014
Latshang TD et al., Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial. JAMA, Dec 12; 308(22): 2390-8. doi:10.1001/jama.2012.94847.

2. Forschungspreis der Schweiz. Gesellschaft für Pneumologie 2014
Latshang TD et al., Effect of traveling to 2590 m on 6-minute walk distance, pulmonary function and symptoms of acute mountain sickness in COPD patients.

3. Forschungspreis der Schweiz. Gesellschaft für Pneumologie 2014
Furian M, Latshang TD et al., Cerebral oxygenation in highlanders with and without high altitude pulmonary hypertension.

4. „Best oral presentation“-Preis der Schweiz. Gesellschaft für Pneumologie 2013
Latshang TD et al., Breathing disorders during sleep in mountaineers with and without high altitude pulmonary hypertension.

5. Swiss Society of Sleep Research, Sleep Medicine and Chronobiology (SSSSC) Sponsor`s Award for the best clinical paper 2013
Nussbaumer-Ochsner Y, Latshang TD et al., Patients with obstructive sleep apnea syndrome benefit from acetazolamide during an altitude sojourn: a randomized, placebo-controlled, double-blind trial. Chest 2012 Jan; 141: 131-8.

6. Prix De Quervain 2012, Swiss Committee on Polar and High Altitude Research
Nussbaumer-Ochsner Y, Latshang TD et al., Patients with obstructive sleep apnea syndrome benefit from acetazolamide during an altitude sojourn: a randomized, placebo-controlled, double-blind trial. Chest 2012 Jan; 141: 131-8.

Originalarbeiten

1. Ulrich S, Hasler E D, Müller-Mottet S, Keusch S, Furian M, Latshang T D, Schneider S, Saxer S, Bloch K E (2017) Mechanisms of improved exercise performance under hyperoxia.
Respiration 93: 90-98
Impact factor 2015: 2.651

2. Latshang T D, Furian M, Aeschbacher S, Ulrich S, Mirrakhimov E M, Sooronbaev T, Aldashev A A, Bloch K E (2017) Association among sleep apnea and pulmonary hypertension in Kyrgyz highlanders.
Eur. Respir. J. 49(2). pii:1601530. doi: 10.1183/13993003.01530-2016
Impact factor 2015: 8.332

3. Lo Cascio C M, Goetze O, Kuyumcu S, Latshang T D, Frauenfelder T, Kohler M, Bloch K E (2016) Gastrointestinal Dysfunction in patients with Duchenne Muscular Dystrophy (DMD).
PLoS One 11: e0163779
Impact factor 2015: 3.057

4. Latshang T D, Kaufmann B, Nussbaumer-Ochsner Y, Ulrich S, Furian M, Kohler, M Thurnheer R, Saguner, A M, Duru F, Bloch K E (2016) Patients with Obstructive Sleep Apnea Have Cardiac Repolarization Disturbances when Travelling to Altitude: Randomized, Placebo-Controlled Trial of Acetazolamide. Sleep 39: 1631-1637 Impact factor 2015: 4.793

5. Latshang T D, Müller D J, Lo Cascio C M, Stöwhas A C, Stadelmann K, Tesler N, Achermann P, Huber R, Kohler M, Bloch K E (2016) Actigraphy of Wrist and Ankle for Measuring Sleep Duration in Altitude Travelers. High Alt. Med. Biol. 17: 194-202
Impact factor 2015: 1.525

6. Franzen D, Ciurea A, Bratton D J, Clarenbach C F, Latshang T D, Russi E W, Kyburz D, Kohler M (2016) Effect of rituximab on pulmonary function in patients with rheumatoid arthritis.
Pulm. Pharmacol. Ther. 37: 24-29
Impact factor 2015: 2.930

7. Furian M, Latshang T D, Aeschbacher S S, Ulrich S, Sooronbaev T, Mirrakhimov E M, Aldashev A, Bloch K E (2015) Cerebral oxygenation in highlanders with and without high-altitude pulmonary hypertension.
Exp. Physiol. 100: 905-914
Impact factor 2015: 2.818
 
8. Garde A, Giraldo B F, Jané R, Latshang T D, Turk A J, Hess T, Bosch M M, Barthelmes D, Merz T M, Hefti J P, Schoch O D, Bloch K E (2015) Time-varying signal analysis to detect high-altitude periodic breathing in climbers ascending to extreme altitude.
Med. Biol. Eng. Comput. 53: 699-712
Impact factor 2015: 1.797

9. Stadelmann K, Latshang T D, Lo Cascio C M, Clark R A, Huber R, Kohler M, Achermann R, Bloch K E (2015) Impaired postural control in healthy men at moderate altitude (1630 m and 2590 m): data from a randomized trial.
PLoS One. 10: e0116695
Impact factor 2015: 3.057

10. Tesler N, Latshang T D, Lo Cascio C M, Stadelmann K, Stoewhas A C, Kohler M, Bloch K E, Achermann R, Huber R (2015) Ascending to moderate altitude impairs overnight memory improvements.
Physiol. Behav. 139: 121-126
Impact factor 2015: 2.461

11. Ulrich S, Nussbaumer-Ochsner Y, Vasic I, Hasler E, Latshang T D, Kohler M, Muehlemann T, Wolf M, Bloch K E (2014) Cerebral oxygenation in patients with obstructive sleep apnea staying at altitude. Data from a randomized, placebo-controlled trial evaluating efficacy of acetazolamide.
Chest 146: 299-308
Impact factor 2015: 5.940

12. Lo Cascio C M, Latshang T D, Kohler M, Fehr T, Bloch K E (2014) Severe metabolic acidosis in adult patients with Duchenne Muscular Dystrophy.
Respiration 87: 499-503
Impact factor 2015: 2.651

13. Stadelmann K, Latshang T D, Nussbaumer-Ochsner Y, Tarokh L, Kohler M, Bloch K E, Achermann P (2014) Impact of acetazolamide and CPAP on cortical activity in obstructive sleep apnea patients.
PLoS One 9: e93931
Impact factor 2015: 3.057

14. Stadelmann K, Latshang T D, Tarokh L, Lo Cascio C M, Tesler N, Stoewhas A C, Kohler M, Bloch K E, Huber R, Achermann P (2014) Sleep respiratory disturbances and arousals at moderate altitude have overlapping EEG spectral signatures.
J. Sleep Res. 23: 463-468
Impact factor 2015: 3.093

15. Ayers L, Stoewhas A C, Ferry B, Latshang T D, Lo Cascio C M, Stadelmann K, Tesler N, Huber R, Achermann P, Bloch K E, Kohler M (2014) Circulating levels of cell-derived microparticles are reduced by mild hypobaric hypoxia: data from a randomised controlled trial.
Eur. J. Appl. Physiol. 114: 1067-1073
Impact factor 2015: 2.328

16. Latshang T D, Lo Cascio C M, Stoewhas A C, Grimm M, Stadelmann K, Tesler N, Achermann P, Huber R, Kohler M, Bloch K E (2013) Are nocturnal breathing, sleep and cognitive performance impaired at moderate altitude (1630-2590 m)?
Sleep 36: 1969-1976
Impact factor 2015: 4.793

17. Stadelmann K, Latshang T D, Lo Cascio C M, Tesler N, Stoewhas A C, Kohler M, Bloch K E, Huber R, Achermann R (2013) Quantitative changes in the sleep EEG at moderate altitude (1630 m and 2590 m).
PLoS One 8: e76945
Impact factor 2015: 3.057

18. Stoewhas A C, Latshang T D, Lo Cascio C M, Lautwein S, Stadelmann K, Tesler N, Ayers L, Berneis K, Gerber P, Huber R, Achermann P, Bloch K E, Kohler M (2013) Effects of acute exposure to moderate altitude on vascular function, metabolism and systemic inflammation.
PLoS One 8: e70081
Impact factor 2015: 3.057

19. Huber F L, Latshang T D, Goede J S, Bloch K E (2013) Does venous blood gas analysis provide accurate estimates of hemoglobin oxygen affinity?
Ann. Hematol. 92: 517-521
Impact factor 2015: 3.022

20. Latshang T D, Nussbaumer-Ochsner Y, Henn R M, Ulrich S, Lo Cascio C M, Ledergerber B, Kohler M, Bloch K E (2012) Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial.
JAMA 308: 2390-2398
Impact factor 2015: 37.684

21. Latshang T D, Turk A J, Hess T, Schoch O D, Bosch M M, Barthelmes D, Merz T M, Hefti U, Pichler Hefti J, Maggiorini M, Bloch K E (2013) Acclimatization improves submaximal exercise economy at 5533 m.
Scand. J. Med. Sci Sports 23: 458-467
Impact factor 2015: 3.025

22. Clarenbach C F, Stoewhas A C, van Gestel A J, Latshang T D, Lo Cascio C M, Bloch K E, Kohler M (2012) Comparison of photophlethysmographic and arterial tonometry-derived indices of arterial stiffness.
Hypertens. Res. 35: 228-233
Impact factor 2015: 3.208

23. Nussbaumer-Ochsner Y, Latshang T D, Ulrich S, Kohler M, Thurnheer R, Bloch K E (2012) Patients with obstructive sleep apnea syndrome benefit from acetazolamide during an altitude sojourn: A randomized, placebo-controlled, double-blind trial.
Chest 141: 131-138
Impact factor 2015: 5.940

24. Bloch K E, Latshang T D, Turk A J, Hess T, Hefti U, Merz T M, Bosch M M, Barthelmes D, Pichler Hefti J, Maggiorini M, Schoch O D (2010) Nocturnal Periodic Breathing during Acclimatization at Very High Altitude at Mount Muztagh Ata (7,546 m).
Am. J. Resp. Crit. Care 182: 562-568
Impact factor 2015: 13.118

25. Puhan M A, Vollenweider D, Latshang T, Steurer J, Steurer-Stey C (2007) Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review.
Respir. Res. 8: 30
Impact factor 2015: 3.751

Fallbeschreibungen (case reports)

1. Bloemberg G V, Keller P M, Stucki D, Trauner A, Borrell S, Latshang T, Coscolla M, Rothe T, Hömke R, Ritter C, Feldmann J, Schulthess B, Gagneux S, Böttger E C (2015) Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis.
N Engl J Med. 373: 1986-1988

2. Franzen D, Latshang T, Frauenfelder T, Russi E W (2010) Be cautious with a prognosis!
Ther Umsch. 67: 605-607


Übersichtsarbeiten (Reviews)

1. Bloch K E, Buenzli J C, Latshang T D, Ulrich S (2015) Sleep at high altitude: guesses and facts.
J Appl Physiol (1985) 119: 1466-1480

2. Bloch K E, Latshang T D, Ulrich S (2015) Patients with Obstructive Sleep Apnea at Altitude.
High Alt Med Biol. 16: 110-116

3. Latshang T D, Bloch K E, Lynm C, Livingston EH (2012) JAMA patient page. Traveling to high altitude when you have sleep apnea.
JAMA 308: 2418

4. Latshang T D, Lo Cascio C M, Russi E W (2012) Is lung cancer screening reasonable?
Ther Umsch. 69: 389-393

5. Latshang T D, Bloch K E (2011) How to treat patients with the obstructive sleep apnea syndrome during an altitude sojourn.
High Alt. Med. Biol. 12: 303-307

6. Latshang T D, Lo Cascio C M, Russi E W (2011) Nontuberculous mycobacterial infections of the lung.
Ther Umsch. 68: 402-406


Buchbeiträge

1. Furger P, et al, Latshang T D (2015) TURBO Notfallmedizin. 3. Ausgabe, Editions D&F GmbH Schweiz, pp.207-238, info@investimed.ch: Neuhausen am Rheinfall


Angeleitete Dissertationen

1. Die Behandlung von Patienten mit Obstruktivem Schlafapnoe Syndrom in der Höhe. Inaugural-Dissertation zur Erlangung der Doktorwürde der Medizinischen Fakultät der Universität Zürich von Rahel Martha Henn von Zell 2011.

2. Effekt eines Höhenaufenthaltes auf Ruhe- und Aktivitätsmuster. Inaugural-Dissertation zur Erlangung der Doktorwürde der Medizinischen Fakultät der Universität Zürich von Daniela Juliana Müller von Hirschthal Aargau 2011.